Citius Pharmaceuticals Inc. (CTXR)
NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 0.51 +1.78%
CTXR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $13.76M
- EPS (TTM)
- -$1.75
- Dividend yield
- None
- 52-week range
- 0.469 – 2.19
- Day range
- 0.4879 – 0.51
- Volume / Avg
- 156.68K / 528.79K
- Beta
- —
- Shares outstanding
- 27.45M
52-week range
CTXR stock today
On Oct 7, CTXR ended the session at $0.5011, adding $0.0204 (4.24%), versus the S&P 500's 0.22% decline. Trading was light, with 156.68K shares changing hands, about 30% of the average daily volume. Shares are 77.1% below their 52-week high of $2.19, set on Oct 20, 2025 and 6.8% above the 52-week low of $0.469, near the bottom of the past year's range.
CTXR is down 35.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 64.2%. Citius Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$1.75), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Citius Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Citius Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BFRIBiofrontera Inc. | 0.9354 | +0.36% | $13.89M | vs CTXR |
| LTRNLantern Pharma Inc. | 0.91 | -4.58% | $13.59M | vs CTXR |
| TPSTTempest Therapeutics Inc. | 0.7914 | +0.50% | $13.37M | vs CTXR |
| CLRBCellectar Biosciences Inc. | 1.51 | 0.00% | $14.27M | vs CTXR |
| HINDVyome Holdings Inc. | 2.04 | -0.97% | $14.32M | vs CTXR |
| BFRGBullfrog AI Holdings Inc. | 0.7086 | +2.84% | $13.14M | vs CTXR |
| KPTIKaryopharm Therapeutics Inc. | 0.645 | -0.75% | $14.63M | vs CTXR |
| TVRDTvardi Therapeutics Inc. | 1.10 | +1.85% | $14.67M | vs CTXR |
Indexes, lists and sector
Citius Pharmaceuticals stock FAQ
What is Citius Pharmaceuticals's stock price today?
CTXR last traded at $0.5011 as of Oct 7, 4:00 PM EDT, up 4.24% on the day. Prices are delayed at least 15 minutes.
Does Citius Pharmaceuticals pay a dividend?
No. Citius Pharmaceuticals does not currently pay a regular cash dividend.
Has CTXR ever split its stock?
Yes. The most recent CTXR stock split was a 1-for-25 split on Nov 26, 2024, one of 2 splits on record.
What is the CTXR 52-week high?
The 52-week high for CTXR is $2.19 and the 52-week low is $0.469. The stock is currently 77.1% below its high.